On the possible mechanism of recognition of DNA base sequence by steroid hormones  by Chandrasekhar, B. et al.
Volume 225, number 1,2, 151-158 FEB 05343 December 1987 
On the possible mechanism of recognition of DNA base 
sequence by steroid hormones 
B. Chandrasekhar, Mrigank and V. Kothekar 
Department of Biophysics, AN India Institute of Medical Sciences, New Delhi 110029, India 
Received 2 October 1987 
Geometry of the complex of a steroid hormone, dexamethasone, with a hexanucleotide sequence from the 
glucocorticoid responsive element d(TGTTCT)z, is optimised here using computer aided geometry simula- 
tion with an energy minimization technique. We have also optimised its geometries with genetically modified 
and arbitrarily chosen DNA sequences. The drug molecule is considered to have both intercalative as well 
as non-intercalative binding. Comparison of energetics and stereochemical aspects, as well as the H-bonding 
scheme, is used here to bring out salient features about the mechanism of DNA sequence recognition by 
steroid hormones. 
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1. INTRODUCTION 
Steroid hormones are believed to enter the 
cytoplasm and bind to specific receptors. The com- 
plex migrates to the nucleus and affects transcrip- 
tion. This classical ‘two-step’ model based on the 
early work of Toft and Gorski [l] and extended by 
Baxter et al. [2] to glucocorticoids has been severe- 
ly challenged. In vitro physicochemical studies 
showed that steroids can directly interact with 
DNA [3-51 whereas recent evidence has shown 
that steroid receptors alone can bind to DNA hor- 
mone responsive elements (HRE) [6,7]. The 
specificity of the receptor recognition is not uni- 
que, in that other steroid receptors can also bind to 
the same sequence of HRE [&lo]. In contrast, the 
presence of hormone is mandatory for steroid 
receptor-HRE interaction to occur in vivo [ 111. To 
date there is no conclusive evidence of whether 
steroid hormone receptor alone can transcribe a 
hormone-dependent gene [ 12-141. It has only been 
Correspondence address: V. Kothekar, Department of 
Biophysics, All India Institute of Medical Sciences, New 
Delhi 110029, India 
demonstrated that the consensus core sequence 
d(TGTTCT)z found in 5 ’ - and 3 ’ -flanking ends of 
glucocorticoid responsive elements of several genes 
can play a significant role in gene regulation. It has 
proved to be an enhancer. 
The above data show the current status of the 
knowledge on the mechanism of steroid action 
and indicate the important role played by steroid- 
DNA interaction. However, the nature of steroid- 
DNA interaction remains obscure. 
Several stereochemical models have been pro- 
posed in the literature for steroid hormone-DNA 
interaction. On the basis of molecular modelling 
(CPK space filling and Kendrew skeletal models) 
Hendry et al. [15] suggested that steroids may be 
capable of inserting between DNA base pairs and 
forming a highly specific transient intercalation 
complex with right-handed double helical DNA. 
Contrary to this, Duax and co-workers [16], on the 
basis of X-ray crystallographic studies on steroid 
hormones, proposed that steroids may recognise 
the DNA base sequence through the D-ring alone 
via specific H-bonds. Receptors can interact at the 
A-ring (see fig.1 for nomenclature). The OHti on 
the P-surface has been shown to be stereospecific 
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for the glucocorticoid receptor [17]. Edelman [18] 
studied the effects of ethidium bromide, proflavin 
sulfate, actinomycin D and netropsin on steroid 
receptor-DNA interaction and concluded that 
binding occurred in the DNA major groove. 
In the present paper we have tried to analyse 
possible modes by which a bulky steroid molecule 
with 'domed' structure can interact with DNA as 
well as bind simultaneously with the receptor 
which can interact with DNA and enhance 
specificity. 
2. EXPERIMENTAL 
2.1. Intercalation model 
The possibility of intercalation was tried with 
two dinucleotide sequences d(TG)2 and d(CG)2. 
We generated the first base pair (TA or  CG) 
following data of Arnott et al. [19]. Cartesian 
coordinates of the steroid were obtained on the 
basis of X-ray crystallographic data [20]. The 
Fig.2. 
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Fig. 1. (a) Nomenclature and rotational angles for dexamethasone. The drug is shown in the plane. The X- and XY-axes 
are depicted. (b) View of the steroid dexamethasone i  the XZ plane depicting or- and H-surfaces as well as protruding 
methyl groups at the 18th and 19th positions. 
152 
Volume 225, number 1,2 FEBS LETTERS December 1987 
hydrogen atoms were inserted by a standard pro- first base pair complex was optimised following 
cedure [21]. A coordinate frame is defined with the same procedure. The base separation was 
respect o the steroid (see fig. 1 for details). The X- found to be 7.2 A. We then generated the DNA 
axis of the steroid is then aligned with the Ci-Ci backbone attached with the 1st and 2nd base pairs. 
vector and the Y-axis with the DNA dyad axis. The Three additional atoms C; -C4 -C; were attached to 
steroid molecule was allowed to rotate around the the backbone of the first base pair. Rotations were 
DNA helix axis from 0 to 360” in 10” intervals. It allowed around Ci-Cl (y), C; -0; (L?), P-0; (a), 
was simultaneously allowed to translate along it P-04 ([), 04 -C; (6) bonds (fig.2). A function con- 
from 3 A to 4 A in 0.1 A intervals. Small sisting of strain (sum of squares of deviation of 
movements were also allowed along the X- and Y- Cartesian coordinates of the atoms C; , C4, C; with 
axis. The drug was assumed to be rigid except for respect to same atoms attached to 2nd base pair) 
small freedom of rotation of the side chain around and conformation energies were calculated and 
the bonds shown in fig. 1. The position of the drug minimised by the damped least square minimiza- 
was optimised on the basis of total energy (interac- tion procedure [24]. Because of large base separa- 
tion plus conformation) calculated using our tion, it was impossible to join backbones without 
previous atom-atom potentials [22,23]. increasing bond lengths and putting unusual strain 
The second base pair was generated in the same on the DNA backbone. Since many steroids such 
way as the first. Its position with respect o steroid- as 19-nor-steroid compounds do not possess pro- 
Table 1 
Comparison of geometric parameters for the intercalating model of d(TG)l with B- 
DNA and average intercalation model 
B-DNA” Average Model 
intercalationb intercalation 
1. Torsional angles (“) 
p” 
; 
; 
-5’ end 
-3’ end 
sugar pucker 
2. Interatomic distances (A) 
Same strand 
Ci-Ci 
P..P 
Opposite strand 
Ci-Ci 
P..P 
3. Turn angle (“) 
between C;-CI 1st pair 
and Ci-Ci 2nd pair 
-39 
- 151 
30 
156 
159 
-98 
-95 
-95 
C; endo 
4.9 7.0 
6.4 6.2 
10.7 11.6 
18.4 16.2 
36 16 
- 70(8) 
- 135(9) 
59( 14) 
- 150(11) 
- 67(7) 
- 163( 12) 
- 76 
Cj endo 5 ’ end 
C; /C; endo 3’ end 
-84 
150 
160 
- 
- 163 
-116 
-158 
-95 
Cj endo 
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truding methyl groups on the p-surface we decided 
to attempt the intercalation model with these 
groups removed. The base pair separation in the 
absence of methyl groups reduced to 6.6 A. The 
backbone could join smoothly. This model is 
depicted in fig.3. The comparison of its geometric 
parameters and energetics for this model is shown 
in tables 1 and 2. 
2.2. Major groove binding model 
Because of steric limitations steroids cannot in- 
teract in the minor groove. The major groove 
binding was attempted following the same pro- 
cedure as that for minor groove binding drugs 
(netropsin, distamycin, dye Hoechst 33258) 
[23,25]. The interaction of dexamethasone was 
studied with the consensus core sequence 
d(TGTTCT)z as well as genetically modified and 
arbitrarily chosen hexanucleotide duplexes (see 
table 3 for details). The model of interaction with 
the core sequence is depicted in fig.4. Comparison 
of the H-bonding pattern and energetics is shown 
in tables 3 and 4. 
3. RESULTS AND DISCUSSION 
3.1. Intercalation model 
3.1.1. Stereochemical aspects 
Several changes in backbone and glycosyl tor- 
a 
sional angles are necessary for extending base pair 
separation from 3.4 A to 6.6 A (table 1). Rotation 
around phosphodiester linkages (cu and {) was in 
-SC conformation. Rotation around C; -0; (6) is in 
the trans-conformation. It is much different from 
the B-DNA model but it is close to the average in- 
tercalation model. Major differences between our 
model and the average intercalation model were 
noticed in the case of angles ,8 and y. The reason 
for this was the difference in sugar pucker between 
our model and classical intercalator models [26]. 
In the average intercalation model, the sugar 
pucker combination for adjacent base pairs had 
been Ci endo-C; endo. In contrast we obtained a 
Ci endo sugar pucker for both base pairs which 
agrees with the daunomycin-DNA complex 
[27,28]. In contrast to conventional DNA models, 
rotation around C4-C; (y) was observed in trans- 
regions similar to Z-DNA [29] and justified by 
molecular orbital calculations [30]. The glycosyl 
angles were in trans- or high anti-region and were 
in the vicinity of average intercalation and B-DNA 
models. 
We observed an increase in the Ci-Cl distance 
in the same strand by 2.1 A. The Ci -Ci distance in 
opposite strands increased by 0.9 A, and the 
P . . . .P distance across the helix was reduced by 
2.2 A. There was unwinding of DNA base pairs by 
about 20”. Glycosyl bonds were in cis- 
conformation. 
b id-- 
Fig.3. Intercalation model showing position of the drug with respect to DNA base pairs in (a) the XY plane and (b) 
the YZ plane. Intercalation complex of d(CG) with dexamethasone. 
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Table 2 
Energy partitioning of intercalation models 
December 1987 
No. Base sequence E,,,, E de + pal Ehydg. &t 
1. d(TG)z - 37.80 - 16.06 - 1.85 - 55.72 
2. d(CG)z - 23.05 - 12.20 - 3.79 - 39.00 
E non, nonbonding interaction energy calculated using Lennard Jones 6-12 
potential; &I~+~~I, electrostatic (monopole-monopole, dipole-induced 
dipole) interaction calculated at dielectric permeability value 4.0 using 
CNDO/II charge distribution; Ehydg., H-bonding energy calculated by 
Momany et al. lo-12 potential [32]; Eint, , total interaction energy of DNA 
with sequence. All energies are in kcal/mol 
The steroid molecule is almost perpendicular to 
the DNA base pair (fig.3a) with its A-ring 
penetrating the minor groove. The D-ring with at- 
tached side chain lies in the major groove. Its OH17 
proton lies within the H-bonding distance of 0s of 
guanine. Its distance in d(TG)2 and d(CG)2 was 2.9 
and 2.6 A, respectively. This model agrees general- 
ly with X-ray crystallographic data on the 
daunomycin d(CGATCG) complex [27]. 
3.1.2. Energetic aspects 
Comparison of total interaction energy shows 
(table 2) that d(TG)2 is preferred over d(CG)z. The 
interaction is stabilized by stacking which con- 
tributes 71.4 and 56.9%, respectively. Steroid has 
slightly more interaction with the 5’-strand in 
d(TG)2 and with the 3’-strand in d(CG)2. 
Preference for d(TG)2 is mainly because of changes 
in the stacking interaction (table 2). Electrostatic 
and H-bonding contributions show a small 
preference for d(CG)z. 
3.2. Major groove model 
3.2.1. Stereochemical aspects 
The model for the interaction of dexamethasone 
in the major groove of the core sequence is 
depicted in fig.4a. The drug molecule is seen to oc- 
cupy a region of over three base pairs. In the first 
b 
Fig.4. (a) Interaction of dexamethasone with the major groove of the core sequence d(TGTTCT)z. Figure clearly shows 
interaction with 3rd, 4th and 5th base pairs. (b) The proposed model for the interaction of the receptor (shown by very 
thick line) with steroid in the major groove of DNA. The figure shows points of contact of the receptor with the A-ring, 
OH 1, and phosphate and bases of DNA. 
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Table 3 
December 1987 
Hydrogen bonding scheme (major groove binding model) 
No. Sequence Atom pair distance Atom pair distance Atom pair distance Atom pair distance 
(A) (A) (A) (A) 
1. d(TGTTCT)z 
2. d(TGGTCT)z 
3. d(TGmCT)z 
4. d(TGaCT)z 
5. d(TmTCT)z 
6. d(TGTACT)l 
7. d(TGTGCT)z 
8. dG6. dC6 
9. d(TATATA)z 
OH,, T04(3) 2.79 OHr, T04(4) 2.89 
OH,, T04(4) 2.90 
OH,, T04(4) 2.90 
OHr, T04(4) 2.90 
OH,, T04(3) 3.04 OHr, T04(4) 2.60 
OHr, T04( -4) 2.95 
OH,, T04(3) 2.79 OH,, G06(4) 2.93 
OHr, G06(4) 2.92 
OHr, T04( -4) 2.56 
OH21 T04(4) 2.28 
OH2, T04(4) 2.24 
OHz, T04(4) 2.24 
OH2, T04(4) 2.24 
OH2, T04( - 4) 2.28 
OH2, T04( -4) 2.64 
OH21 GOs(4) 1.92 
OHz, G06(4) 1.98 
OH2, T04( -4) 2.19 
OHS, GOe(-5) 1.94 
OH2, G06( - 5) 1.97 
OH21 GOe( - 5) 1.97 
OH2, GOe( - 5) 1.97 
OH21 GOe( - 5) 1.94 
OHz, G06( - 5) 2.04 
OH2, G06( - 5) 2.91 
OH21 G06(5) 2.44 
OH21 AN,(-5) 2.77 
The first sequence is the core sequence. Other sequences have a mutation (shown by underlining) at 2nd, 3rd or 4th 
position (positions involved in H-bonding). Numbers in parentheses represent base pair position. The distance between 
proton (H) and electron donor (x) is given here 
five sequences considered by us (table 3) thymine 
at the fourth position and guanine at position ( - 5) 
are invariant. As a result OHi7 and OH21 form H- 
bonds with thymine 04 or guanine 06 at 4th and 
5th positions. Mutations at the fourth position 
alter the H-bonding pattern. Replacement of 
guanine for thymine does not affect H-bonds as 06 
can be involved in H-bonding in place of 04. In the 
case of replacement of thymine by adenine the 
drug readjusts its position and forms an H-bond 
with 04 of T-4. 
3.2.2. Energetic aspects 
The net difference in the interaction energy of 
the core sequence and genetically modified se- 
quences was small. All three types of interactions 
(nonbonding, electrostatic and H-bonding) con- 
tributed towards it (table 4). The core sequence (se- 
quence 1) and one mutated sequence where 
guanine at the second position was replaced by 
adenine (sequence 5) had almost the same energy 
and were the most preferred sequences. The max- 
imum difference in the electrostatic interaction was 
observed between dG6. dC6 and d(TATATA)z. 
This was due to difference in the electrostatic 
potential in the major groove of these two se- 
quences [31]. Maximum contribution due to H- 
bonding interaction was observed in the case of 
Table 4 
Interaction energy break ups (kcal/mol) for major groove binding model 
No. Hexanucleotides non E E d.Z+DOl Ehydz. Eint 
1. d(TGTTCT)z 
2. d(TGmCT)z 
3. d(TG&TCT)z 
4. d(TGaCT)z 
5. d(T&TTCT)z 
6. d(TGT&ZT)z 
7. d(TGTGCT)z 
8. dG6. dC6 
9. d(TATATA)z 
- 23.60 
- 20.47 
-21.01 
- 23.24 
- 24.95 
-21.33 
- 25.31 
- 22.59 
- 17.94 
- 17.93 
- 16.54 
- 17.77 
- 17.37 
- 18.28 
- 18.25 
- 16.07 
- 15.20 
-21.22 
- 9.67 
- 8.60 
-8.16 
-7.15 
- 9.54 
- 8.24 
- 8.93 
- 7.37 
- 8.00 
- 52.04 
-45.61 
- 47.01 
- 47.77 
- 52.77 
- 47.83 
- 50.33 
- 45.03 
-47.18 
Energy parameters I&,,, I!$+.+~~I, Ehydg., Eint, have the same meaning as in 
table 2 
156 
Volume 225, number 1,2 FEBS LETTERS December 1987 
core sequence. This as we believe is the primary 
reason for the preference of core sequence in 5 ’ - 
and 3 ‘-flanking ends of GRE of many organisms 
[12-141. 
3.3. Receptor binding 
In the case of the intercalation model OHi1 is 
deeply buried within DNA base pairs and the 
receptor molecule cannot interact with it. The drug 
can interact with the receptor through the A-ring in 
the minor groove. However, the minor groove of 
the B-form of DNA is too small to accommodate 
the receptor. 
In the case of the major groove binding model 
OHii on the&surface as well as the A-ring are free 
to interact with the receptor in the major groove. 
Not only can the major groove accommodate the 
steroid receptor complex but there can also be 
specific contacts between receptor and DNA 
(fig.4b) which would enhance specificity. 
4. CONCLUSION 
The results presented here clearly demonstrate 
preference of the major groove binding model over 
intercalation for dexamethasone. In the case of 
other steroids such as 19-nor-steroid compounds 
where methyl groups are absent the intercalation 
model may be feasible stereochemically. Although 
the specificity in the case of the intercalation model 
is higher, it is difficult to explain the interaction of 
the receptor-steroid complex with DNA on the 
basis of this model. 
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